Parkinson’s disease questions

Discovered in 1817 by a British doctor who gave his name, Parkinson’s disease affects 4 million people worldwide. On the 100 000 to 150 000 likely PD in France, only 80,000 are known and followed. Too often still slow and earthquakes are attributed to the simple effect of aging.

Each year 8 000 new cases occur. Although this disease usually starts between the ages of 55 and 65, 5 to 10% of patients suffer at well less advanced ages (between 30 and 55 years).

Parkinson's disease

What is Parkinson’s disease?
Discovered in 1817, Parkinson’s disease is still far from having delivered all its secrets. Affecting the nervous system, its cause is still not known. The disease is characterized by the disappearance of a small number of nerve cells (neurons) that secrete a neurotransmitter called dopamine involved in the proper functioning of many regions of the brain, and essential to the survival of cells. Continue reading “Parkinson’s disease questions”

Parkinson’s disease: a difficult diagnosis

At the beginning of the disease, the diagnosis of Parkinson’s disease is difficult because symptoms may go unnoticed. Nevertheless several criteria now allow to carry a reliable diagnosis… If not early.

The symptoms of Parkinson’s disease are progressive and little specific: fatigue, pain, rheumatism, depression… This is why the national agency of Accreditation and assessment in health (predecessor of the high authority of health) listed specifically in 2000 the criteria according to which the parkinsonian diagnosis could and should be established.

Parkinson's

The clinical criteria of Parkinson’s disease
The diagnosis of Parkinson’s disease is based on the review and examination of the patient, looking for symptoms previously observed. Continue reading “Parkinson’s disease: a difficult diagnosis”

Support for Parkinson’s disease

Despite the latest medical advances, there is not today’s cure for Parkinson’s disease. But the support allows to correct the symptoms. The point with the Parkinson association.

Currently there is not a cure of Parkinson’s disease but since 1960, new treatments or discoveries occur. Drugs allow a resumption of activities in 80% of cases. For Pr Pierre Cesaro, neurologist, Chairman of the Scientific Committee of the Association France Parkinson, “new treatments allow to improve the quality of life of patients and extend their life expectancy of ten years from the 1970s. Among them, the brain stimulation reproduced stably the best effect of medical treatment“.

Parkinson's Disease Programme

Drug treatments
Fifty years after the discoveries of Arvid Carlsson (Nobel Prize 2000) on dopamine, which gave birth to the treatment for Parkinson’s disease, researchers are still working to better treat the symptoms failing to cure the disease. It is indeed known still not stop to date, or even slow down the process of destruction of neurons that produce dopamine.
THE BENCHMARK TREATMENT: LEVO-DOPA Continue reading “Support for Parkinson’s disease”

The management of Parkinson’s disease

Despite recent medical advances, there is currently no cure for Parkinson’s disease. But support can correct symptoms. The point with the Association France Parkinson.

Currently there is no cure for Parkinson’s disease but, since 1960, new treatments and discoveries succeed. Drugs allow a resumption of activities in 80% of cases. For Professor Pierre Cesaro, neurologist, Chairman of the Scientific Committee of the Association France Parkinson, “new treatments can improve the quality of life of patients and extend their life expectancy of ten years compared to 1970s. Among them, the brain stimulation reproduced stably the best effect of medical treatment. ”

Parkinson's disease

Drug treatments
Fifty years after the discoveries of Arvid Carlsson (Nobel Prize 2000) on dopamine, which gave rise to the standard treatment for Parkinson’s disease, researchers are still trying to better treat the symptoms if they can not cure the disease . We do not know in fact still stop to date, or even slow down the destruction of neurons that produce dopamine. Continue reading “The management of Parkinson’s disease”

Parkinson’s disease: healing the body and mind

In addition to the new extended-release drug treatment, research focuses on the psycho-social aspects of Parkinson’s disease. An important to lift the veil on many prejudices and allow patients to exonerate it.

A man aged 45 has fixed lines and walk “weird.” There is, however, neither depressed nor under the influence of alcohol. It is parkinsonism. Besides tremors (2/3 of people with Parkinson’s do not shake) the misconceptions about the disease are numerous. Fortunately, management becomes increasingly global and psycho-social consequences begin to be taken into account.

the body and mind

Parkinson take charge of the body and mind
The doctors are considering the establishment of an announcement protocol, so that the diagnosis of Parkinson’s disease is not mentioned too abruptly. “It usually takes a year to integrate the new. Ago phases of denial, rejection and many people who try to hide as long as possible Parkinson their families. A counseling is recommended to help live well every day, “said Dr. Thierry Hergueta, a psychologist at the Pitie Salpetriere hospital in Paris. Continue reading “Parkinson’s disease: healing the body and mind”

A Parkinson when a Plan?

Great forgotten neurodegenerative diseases, Parkinson’s disease receives no National Plan unlike Alzheimer’s disease in particular. This results in a lack of coordination in the management and research, to the detriment of patients and their families.

One year after the White Paper on Parkinson’s disease , which offered twenty measures to improve the management of patients at the time of diagnosis, help them cope with their disease and boost research, progress is stalled almost. The Association France Parkinson calls the government.

Parkinson when a Plan

Parkinson, the great “forgotten” neurodegenerative diseases
On the eve of the World Parkinson’s Day, April 11, the Association Parkinson calls on the State to launch urgently a national Parkinson Plan, like those that exist for other diseases, particularly for the Alzheimer disease . If the association has decided to act, it is estimated that Parkinson’s disease , which in France each year 14,000 new victims, is “the most overlooked of neurodegenerative diseases . ” “Today, solutions and concrete paths exist in support, but lack of resources, they are not coordinated nationally. There is no coverage of the French territory known visible and dynamic,” laments the association. Continue reading “A Parkinson when a Plan?”

Neurostimulation against Parkinson’s disease

It is possible for several years to improve the symptoms of patients with Parkinson’s disease by stimulating deep brain area. This surgical procedure is not available to all patients. Benefits, indications, techniques … Doctissimo an update.

This method is now practiced in over twenty centers in France and concern 300 new patients each year.
Neurostimulation: a beautiful story.
Neurostimulation is a beautiful scientific history, which began with experimental work. The researchers knew that the injury sub-thalamic nucleus (particular area of the brain) improves Parkinson’s symptoms in monkeys. But to go from this observation to the development of neurostimulation, it took two innovations, as recalled Prof. Agid the Salpêtrière (Paris), at the 7th International Forum on Parkinson’s disease.

Parkinson's  disease

“Researchers from Bordeaux showed that poses an electrode supplied with electric current in the brain of an animal used to suppress parkinsonian symptoms caused. These results were immediately taken by the team of Prof. Benabib and Pollak in Grenoble , who has applied to the brain of the patient.’s great trick was to use a pacemaker to transform the transient effect in permanent effect on the deep brain structures. ” Continue reading “Neurostimulation against Parkinson’s disease”

Parkinson’s disease: a difficult diagnosis

At the beginning of the disease, the diagnosis of Parkinson’s disease is difficult because the symptoms can go unnoticed. Nevertheless, several criteria can now wear a reliable diagnosis … if not early.

The symptoms of Parkinson’s disease is progressive and nonspecific: fatigue, pain, rheumatism, depression … This is why the National Agency for Accreditation and Evaluation in Health (predecessor of the High Authority for Health) listed specifically in 2000 the criteria for Parkinson’s diagnosis could and should be established.

Parkinson's Disease

The clinical criteria for Parkinson’s disease
The diagnosis of Parkinson’s disease based on a review and examination of the patient, for symptoms previously observed. Continue reading “Parkinson’s disease: a difficult diagnosis”

Parkinson’s disease in question

Discovered in 1817 by a British physician who gave him his name, Parkinson’s disease affects 4 million people in the world. Of the 100 000 a 150 000 probable PD, only 80,000 are known and followed. Too often slow and earthquakes are attributed to the simple fact of aging.

Each year, 8,000 new cases. Although the disease usually starts between 55 and 65 years, 5 to 10% of patients have at much younger ages (between 30 and 55 years).

parkinson's

What is Parkinson’s disease?
Discovered in 1817, Parkinson’s disease is still far from having revealed all its secrets. Nervous system, its cause is still unknown. The disease is characterized by the disappearance of a small number of nerve cells (neurons) that secrete a neurotransmitter called dopamine involved in the proper functioning of many parts of the brain and essential for cell survival.Connection between two neurons. Continue reading “Parkinson’s disease in question”